- Home
- ENLV vs BNGO Comparison
ENLV vs BNGO Comparison
Compare ENLV & BNGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ENLV
- BNGO
- Stock Information
- Founded
- ENLV 2005
- BNGO 2003
- Country
- ENLV Israel
- BNGO United States
- Employees
- ENLV N/A
- BNGO N/A
- Industry
- ENLV Biotechnology: Pharmaceutical Preparations
- BNGO Biotechnology: Laboratory Analytical Instruments
- Sector
- ENLV Health Care
- BNGO Industrials
- Exchange
- ENLV Nasdaq
- BNGO Nasdaq
- Market Cap
- ENLV 31.5M
- BNGO 28.7M
- IPO Year
- ENLV 1995
- BNGO 2018
- Fundamental
- Price
- ENLV $1.09
- BNGO $0.26
- Analyst Decision
- ENLV Strong Buy
- BNGO Hold
- Analyst Count
- ENLV 2
- BNGO 3
- Target Price
- ENLV $9.50
- BNGO $1.00
- AVG Volume (30 Days)
- ENLV 173.7K
- BNGO 3.4M
- Earning Date
- ENLV 11-30-2024
- BNGO 11-13-2024
- Dividend Yield
- ENLV N/A
- BNGO N/A
- EPS Growth
- ENLV N/A
- BNGO N/A
- EPS
- ENLV N/A
- BNGO N/A
- Revenue
- ENLV N/A
- BNGO $36,579,000.00
- Revenue This Year
- ENLV N/A
- BNGO N/A
- Revenue Next Year
- ENLV N/A
- BNGO $21.35
- P/E Ratio
- ENLV N/A
- BNGO N/A
- Revenue Growth
- ENLV N/A
- BNGO 16.08
- 52 Week Low
- ENLV $1.08
- BNGO $0.24
- 52 Week High
- ENLV $4.59
- BNGO $2.27
- Technical
- Relative Strength Index (RSI)
- ENLV 27.79
- BNGO 33.68
- Support Level
- ENLV $1.13
- BNGO $0.27
- Resistance Level
- ENLV $1.33
- BNGO $0.38
- Average True Range (ATR)
- ENLV 0.10
- BNGO 0.03
- MACD
- ENLV -0.02
- BNGO 0.00
- Stochastic Oscillator
- ENLV 6.52
- BNGO 11.36
About ENLV Enlivex Therapeutics Ltd.
Enlivex Therapeutics Ltd is an Israel-based development-stage biopharmaceutical company. It is focused on developing and commercializing an allogeneic drug pipeline for rebalancing immune hyper-responses. The company's Allocetra is an immunotherapy that is being developed to rebalance a life-threatening unbalanced immune system, using the immune system's own natural regulation mechanisms.
About BNGO Bionano Genomics Inc.
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes. Geographically, it operates in Americas, EMEA and Asia Pacific; majority revenue being generated from Americas. They generate product revenue from sales of its OGM and Ionic Purification systems and consumables, which includes its instruments, and their VIA software.